Cite

HARVARD Citation

    Ahn, M. et al. (n.d.). 492OOsimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC. Annals of oncology. p. . [Online]. 
  
Back to record